Sector#Biotechnology / R&D Services
- #Digestive system
- #Diseases of the nervous system
- #Infectious and parasitic diseases
- #Pregnancy - childbirth and the puerperium
- #Respiratory system
- #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified
Impact Omics is establishing a lab service based on a proprietary genomics workflow to aid general practitioners in Primary Care with their treatment selection for various (infectious) diseases.
Upcoming eventsAll events
Latest newsMore news
Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase
2 hours ago
Triple discovery unveils insights into type 2 diabetes
Thursday September 28th 2023
SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.
Wednesday September 27th 2023